Health & Biotech Health Kick Podcast: How TALi Digital is using gamification to spot attention deficit issues in children September 3, 2021 Stockhead’s resident health and biotech expert Tim Boreham is putting down the microscope and picking up the microphone for another instalment… ASX Health Stocks: Neuroscientific pockets $25m R&D incentive, MGC Pharma jumps 15% on India approval for COVID-19 drug September 3, 2021 Neurological disorder specialist, Neuroscientific Biopharma (ASX:NSB), announced that research work on its lead drug EmtinB has received a tax incentive… MGC Pharma’s lead product CimetrA one step closer to a registered medicine for COVID-19 patients in India September 3, 2021 Special Report: MGC Pharma (ASX:MXC) has been granted import approval into India for its phytomedicine CimetrA as it moves toward obtaining… Good timing, and flexible funding: Why Dimerix’s $20m share placement is ‘transformational’ for the business, with CEO Nina Webster September 3, 2021 Special Report: The placement gives Dimerix a flexible, long-term funding solution as the Phase 3 clinical trial kicks off with… Chart of the Day: Brainchip (ASX:BRN) is winding tighter – which way will it give? September 2, 2021 Brainship is a fantastic trading stock, in uptrend over two years, and with a tendency to put huge runs on… Skin Elements flags commercialisation plans for its COVID-19 disinfectant spray after securing key TGA approval September 2, 2021 Special Report: The approval from TGA was a major milestone for Skin Elements, and allows it to execute its commercialisation… Wellnex Life shares jump after the company secures distribution deal with supermarket giant Coles September 2, 2021 Special Report: The deal is the latest in a string of market breakthroughs for WNX, which is now executing on… Check Up: Dimerix and ImpediMed announced breakthroughs, while earnings dominate news flow in August September 2, 2021 Although earnings results were the main theme in August, there were also some notable healthcare breakthroughs for ASX health stocks. ASX Health Stocks: Memphasys jumps on legal settlement after flaw with its Felix sperm-separating device September 1, 2021 Biotech company Memphasys (ASX:MEM) was top of the health stocks today, rising 6.78% after announcing it had reached a legal… Neuroscientific Biopharmaceuticals says EmtinB shows promise as a multiple sclerosis treatment August 31, 2021 Special Report: The breakthrough announcement by NeuroScientific Biopharma today elevates its lead drug EmtinB to hunt down the $20bn multiple… Next» « Previous